#YonhapInfomax #HanmiScience #OperatingProfit #HealthcareBusiness #HanmiPharmaceutical #Q3Earnings #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=87930
Hanmi Science Posts 75.2% Surge in Q3 Operating Profit to 39.3 Billion Won—Driven by Healthcare and Distribution Gains (Comprehensive)
Hanmi Science Co. reported a 75.2% year-on-year surge in Q3 operating profit to 39.3 billion won, driven by strong healthcare and pharmaceutical distribution sales, while key subsidiary Hanmi Pharmaceutical advanced global competitiveness through new drug developments and international partnerships.
